These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 19492488)

  • 41. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries.
    Kieler H; Artama M; Engeland A; Ericsson O; Furu K; Gissler M; Nielsen RB; Nørgaard M; Stephansson O; Valdimarsdottir U; Zoega H; Haglund B
    BMJ; 2012 Jan; 344():d8012. PubMed ID: 22240235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Prospective Study Evaluating the Effects of SSRI Exposure on Cardiac Size and Function in Newborns.
    Ansah DA; Reinking BE; Colaizy TT; Roghair RD; Haskell SE
    Neonatology; 2019; 115(4):320-327. PubMed ID: 30836356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Selective serotonin reuptake inhibitors and pregnancy].
    Hassanzadeh T; Pedersen LH; Videbech P
    Ugeskr Laeger; 2014 Feb; 176(3):236-9. PubMed ID: 24629751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hub distribution of the brain functional networks of newborns prenatally exposed to maternal depression and SSRI antidepressants.
    Rotem-Kohavi N; Williams LJ; Muller AM; Abdi H; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
    Depress Anxiety; 2019 Aug; 36(8):753-765. PubMed ID: 31066992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective serotonin reuptake inhibitors' passage into human milk of lactating women.
    Pogliani L; Baldelli S; Cattaneo D; Pileri P; Clementi E; Cetin I; Zuccotti G
    J Matern Fetal Neonatal Med; 2019 Sep; 32(18):3020-3025. PubMed ID: 29557689
    [No Abstract]   [Full Text] [Related]  

  • 46. Safety of selective serotonin reuptake inhibitors in pregnancy.
    Alwan S; Friedman JM
    CNS Drugs; 2009; 23(6):493-509. PubMed ID: 19480468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistent pulmonary hypertension of the newborn and selective serotonin reuptake inhibitors: lessons from clinical and translational studies.
    Occhiogrosso M; Omran SS; Altemus M
    Am J Psychiatry; 2012 Feb; 169(2):134-40. PubMed ID: 22420034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prenatal SSRI exposure: Effects on later child development.
    Hermansen TK; Melinder A
    Child Neuropsychol; 2015; 21(5):543-69. PubMed ID: 25089614
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.
    Sie SD; Wennink JM; van Driel JJ; te Winkel AG; Boer K; Casteelen G; van Weissenbruch MM
    Arch Dis Child Fetal Neonatal Ed; 2012 Nov; 97(6):F472-6. PubMed ID: 23080479
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neonatal complications after intrauterine exposure to SSRI antidepressants.
    Prescrire Int; 2004 Jun; 13(71):103-4. PubMed ID: 15233148
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
    Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
    Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Further findings linking SSRIs during pregnancy and persistent pulmonary hypertension of the newborn: clinical implications.
    Galbally M; Gentile S; Lewis AJ
    CNS Drugs; 2012 Oct; 26(10):813-22. PubMed ID: 22950489
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
    El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H
    Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence.
    Alwan S; Friedman JM; Chambers C
    CNS Drugs; 2016 Jun; 30(6):499-515. PubMed ID: 27138915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prenatal exposure to antidepressants: how safe are they?
    Steiner M
    Am J Psychiatry; 2012 Nov; 169(11):1130-2. PubMed ID: 23128917
    [No Abstract]   [Full Text] [Related]  

  • 56. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
    Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
    JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adverse effects in neonates exposed to SSRIs and SNRI in late gestation--Motherisk Update 2008.
    Koren G; Boucher N
    Can J Clin Pharmacol; 2009; 16(1):e66-7. PubMed ID: 19164848
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose.
    Roca A; Garcia-Esteve L; Imaz ML; Torres A; Hernández S; Botet F; Gelabert E; Subirà S; Plaza A; Valdés M; Martin-Santos R
    J Affect Disord; 2011 Dec; 135(1-3):208-15. PubMed ID: 21890210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn.
    Andrade SE; McPhillips H; Loren D; Raebel MA; Lane K; Livingston J; Boudreau DM; Smith DH; Davis RL; Willy ME; Platt R
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):246-52. PubMed ID: 19148882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
    Salisbury AL; O'Grady KE; Battle CL; Wisner KL; Anderson GM; Stroud LR; Miller-Loncar CL; Young ME; Lester BM
    Am J Psychiatry; 2016 Feb; 173(2):147-57. PubMed ID: 26514656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.